Patrick Roberts is the founder of Incyclix Bio. Incyclix Bio has raised $11M in total funding. Latest round: Series B. Based in Durham, United States.
Patrick Roberts is the Chief Executive Officer and co-founder of Incyclix Bio, an RTP-based company focused on developing treatments for hard-to-treat cancers. Incyclix Bio is advancing INX-315, an oral inhibitor of cyclin-dependent kinase 2 (CDK2) for advanced and resistant cancers, which is currently in a first-in-human clinical trial. The company recently secured a $11.25 million extension to its Series B financing to further its clinical study.
Full founder directory · Investor directory · Company funding database · Fundraising library